Data / Form D filings / Innate Pharma, SA

Innate Pharma, SA: Form D filing

Innate Pharma, SA, a pharmaceuticals company in Marseille, France, filed a Form D with the SEC in 2014. The latest, on January 31, 2014, reports $27.4 million sold of a $27.4 million offering to 6 investors.

Find out what Innate Pharma, SA does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address

117 AVENUE DE LUMINY, Marseille, France, 13009

Phone

01133430303030

Industry

Pharmaceuticals

Entity type

Limited Liability Company

Incorporated in

France

Revenue range

$5,000,001 - $25,000,000

Exemptions claimed

Rule 506(b)

SEC identifier (CIK)

1598599

The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

Executive officers and directors named in the filing

Every Form D from the week of Jan 27, 2014 · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Innate Pharma, SA reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.